{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:37:26Z","timestamp":1793385446398,"version":"4.5.0"},"reference-count":177,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013543","name":"European Society for Paediatric Infectious Disease","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jinf.2019.10.008","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T01:52:55Z","timestamp":1571363575000},"page":"471-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":350,"title":["The effect of antibiotics on the composition of the intestinal microbiota - a systematic review"],"prefix":"10.1016","volume":"79","author":[{"given":"Petra","family":"Zimmermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2019.10.008_bib0001","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/1574-6976.12075","article-title":"The first 1000 cultured species of the human gastrointestinal microbiota","author":"Rajilic-Stojanovic","year":"2014","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jinf.2019.10.008_bib0002","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2019.10.008_bib0003","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jinf.2019.10.008_bib0004","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41587-018-0009-7","article-title":"A human gut bacterial genome and culture collection for improved metagenomic analyses","author":"Forster","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0005","doi-asserted-by":"crossref","first-page":"16203","DOI":"10.1038\/nmicrobiol.2016.203","article-title":"Culture of previously uncultured members of the human gut microbiota by culturomics","author":"Lagier","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0006","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13059-016-0921-4","article-title":"Talking about cross-talk: the immune system and the microbiome","author":"Zeevi","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0007","article-title":"Association between the intestinal microbiota and allergic sensitization, eczema, and asthma: A systematic review","author":"Zimmermann","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0008","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1016\/j.vaccine.2018.04.066","article-title":"The influence of the intestinal microbiome on vaccine responses","author":"Zimmermann","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2019.10.008_bib0009","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jpeds.2011.05.033","article-title":"Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants","author":"Kuppala","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.jinf.2019.10.008_bib0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1542\/peds.2007-3423","article-title":"Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants","author":"Cotten","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jinf.2019.10.008_bib0011","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/cea.12356","article-title":"Prenatal and post-natal exposure to antibiotics and risk of asthma in childhood","author":"Metsala","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jinf.2019.10.008_bib0012","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000455216","article-title":"Early-Life Antibiotic Exposure, Gut Microbiota Development, and Predisposition to Obesity","author":"Azad","year":"2017","journal-title":"Nestle Nutr Inst Workshop Ser"},{"key":"10.1016\/j.jinf.2019.10.008_bib0013","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.intimp.2018.10.021","article-title":"Antibiotics and autoimmune and allergy diseases: Causative factor or treatment?","author":"Strzepa","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0014","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0924-8579(00)00227-2","article-title":"Development and persistence of multi-resistance to antibiotics in bacteria; an analysis and a new approach to this urgent problem","author":"van der Waaij","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2019.10.008_bib0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature10571","article-title":"Ecology drives a global network of gene exchange connecting the human microbiome","author":"Smillie","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2019.10.008_bib0016","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/AAC.50.2.596-599.2006","article-title":"In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers","author":"Lester","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0017","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.tim.2004.07.004","article-title":"Human intestinal bacteria as reservoirs for antibiotic resistance genes","author":"Salyers","year":"2004","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0018","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s000180200007","article-title":"The role of conjugative transposons in spreading antibiotic resistance between bacteria that inhabit the gastrointestinal tract","author":"Scott","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jinf.2019.10.008_bib0019","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/AAC.35.1.185","article-title":"Inducible transfer of conjugative transposon Tn1545 from Enterococcus faecalis to Listeria monocytogenes in the digestive tracts of gnotobiotic mice","author":"Doucet-Populaire","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/AAC.50.1.171-177.2006","article-title":"Ciprofloxacin and trimethoprim cause phage induction and virulence modulation in Staphylococcus aureus","author":"Goerke","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0021","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"Bmj"},{"key":"10.1016\/j.jinf.2019.10.008_bib0022","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02113603","article-title":"Comparative effects of cefadroxil and phenoxymethylpenicillin on the normal oropharyngeal and intestinal microflora","author":"Adamsson","year":"1997","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.10.008_bib0023","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF01816741","article-title":"Impact of different betalactam antibiotics on the normal human flora, and colonization of the oral cavity, throat and colon","author":"Heimdahl","year":"1982","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.10.008_bib0024","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/inf.1979.11.issue-3.11","article-title":"Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man","author":"Heimdahl","year":"1979","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/jac\/15.3.319","article-title":"The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile","author":"Ambrose","year":"1985","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0026","first-page":"e01693","article-title":"Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces","author":"Zaura","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.jinf.2019.10.008_bib0027","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4161\/gmic.29558","article-title":"Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: a randomized clinical trial","author":"Pallav","year":"2014","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jinf.2019.10.008_bib0028","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1128\/JCM.43.11.5588-5592.2005","article-title":"Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge","author":"De La Cochetiere","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0029","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/jac\/38.6.927","article-title":"Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection","author":"Stark","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/00365549409011783","article-title":"Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis","author":"Floor","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0031","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/BF02009388","article-title":"Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora","author":"Brismar","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0032","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/00365549109023408","article-title":"Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment","author":"Black","year":"1991","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0033","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF01644947","article-title":"Swedish Study Group. A randomized multicenter trial to compare the influence of cefaclor and amoxycillin on the colonization resistance of the digestive tract in patients with lower respiratory tract infection","author":"Christensson","year":"1991","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.10.008_bib0034","doi-asserted-by":"crossref","first-page":"S446","DOI":"10.1007\/BF01659768","article-title":"Effect of bacampicillin on human mouth, throat and colon flora","author":"Heimdahl","year":"1979","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.10.008_bib0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1179\/joc.2001.13.3.299","article-title":"Effect of perorally administered pivmecillinam on the normal oropharyngeal, intestinal and skin microflora","author":"Sullivan","year":"2001","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0036","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/00365548609032323","article-title":"Impact of azlocillin on the colon microflora","author":"Nord","year":"1986","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0037","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01644122","article-title":"The influence of flucloxacillin and amoxicillin with clavulanic acid on the aerobic flora of the alimentary tract","author":"Vlaspolder","year":"1987","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.10.008_bib0038","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/19490976.2016.1267890","article-title":"Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers","author":"Kabbani","year":"2017","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jinf.2019.10.008_bib0039","doi-asserted-by":"crossref","first-page":"e50257","DOI":"10.1371\/journal.pone.0050257","article-title":"Long-term changes in human colonic Bifidobacterium populations induced by a 5-day oral amoxicillin-clavulanic acid treatment","author":"Mangin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2019.10.008_bib0040","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/JCM.42.3.1203-1206.2004","article-title":"Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota","author":"Young","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0041","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jac\/24.suppl_B.221","article-title":"Impact of ticarcillin\/clavulanate on the intestinal microflora","author":"Nord","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0042","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/00365548709117204","article-title":"Impact of cefaclor on the normal human oropharyngeal and intestinal microflora","author":"Nord","year":"1987","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0043","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/AAC.31.3.443","article-title":"Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor","author":"Finegold","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0044","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/AAC.36.1.144","article-title":"Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers","author":"Lode","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/08910609309141326","article-title":"Impact of Cefuroxime-axetil on the Normal Intestinal Microflora","author":"Edlund","year":"1993","journal-title":"Microbial Ecology in Health and Disease"},{"key":"10.1016\/j.jinf.2019.10.008_bib0046","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1086\/513755","article-title":"Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy","author":"Edlund","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0047","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/AAC.26.3.343","article-title":"Alterations in human fecal flora, including ingrowth of Clostridium difficile, related to cefoxitin therapy","author":"Mulligan","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0048","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/00365549109023409","article-title":"Effect of loracarbef on the normal oropharyngeal and intestinal microflora","author":"Nord","year":"1991","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0049","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3109\/00365548809032504","article-title":"Impact of cefixime on the normal intestinal microflora","author":"Nord","year":"1988","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/19739478.1995.12461321","article-title":"Betalactam therapy and intestinal flora","author":"Novelli","year":"1995","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0051","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jac\/12.2.163","article-title":"Effect of cefoperazone on faecal flora","author":"Alestig","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0052","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/AAC.22.2.226","article-title":"Impact of cefoperazone therapy on fecal flora","author":"Mulligan","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0053","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01645354","article-title":"The effect of ceftriaxone on the anaerobic bacterial flora and the bacterial enzymatic activity in the intestinal tract","author":"Welling","year":"1991","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.10.008_bib0054","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/00365549109105188","article-title":"Effect of intramuscular ceftriaxone on aerobic oral and faecal flora of 11 healthy volunteers","author":"de Vries-Hospers","year":"1991","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0055","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3109\/00365529008997595","article-title":"Short-chain fatty acid and organic acid concentrations in feces of healthy human volunteers and their correlations with anaerobe cultural counts during systemic ceftriaxone administration","author":"Meijer-Severs","year":"1990","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0056","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2362.1988.tb01256.x","article-title":"Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microflora","author":"Arvidsson","year":"1988","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jinf.2019.10.008_bib0057","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00365548509070424","article-title":"Ceftriaxone: pharmacokinetics and effect on the intestinal microflora in patients with acute bacterial infections","author":"Nilsson-Ehle","year":"1985","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0058","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1198-743x.2001.00264.x","article-title":"Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia","author":"Vogel","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2019.10.008_bib0059","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/jac\/46.4.603","article-title":"Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil","author":"Orrhage","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF01728916","article-title":"Effect of ceftibuten on the normal intestinal microflora","author":"Brismar","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.10.008_bib0061","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijantimicag.2015.02.027","article-title":"Ecological effect of ceftazidime\/avibactam on the normal human intestinal microbiota","author":"Rashid","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2019.10.008_bib0062","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jac\/30.3.365","article-title":"Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers","author":"Bacher","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0063","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/29.suppl_A.81","article-title":"Influence of cefpirome on pharyngeal and faecal flora after single and multiple intravenous administrations of cefpirome to healthy volunteers","author":"Knothe","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0064","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/AAC.01716-09","article-title":"Effect of ceftaroline on normal human intestinal microflora","author":"Panagiotidis","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0065","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/AAC.00530-15","article-title":"Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota","author":"Rashid","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0066","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijantimicag.2010.07.021","article-title":"Effect of ceftobiprole on the normal human intestinal microflora","author":"Backstrom","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2019.10.008_bib0067","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF01963943","article-title":"Effect of meropenem on the intestinal microflora","author":"Bergan","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0068","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/jac\/33.5.987","article-title":"Pharmacokinetics and safety of BO-2727, a new injectable 1-beta-methyl carbapenem antibiotic, and its effect on the faecal microflora in healthy male volunteers","author":"Nakashima","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0069","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF01712452","article-title":"The effect of FCE 22891, a new oral penem, on faecal flora anaerobes and their fermentation end products in patients with chronic obstructive pulmonary disease","volume":"21","author":"Meijer-Severs","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.10.008_bib0070","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/infdis\/173.5.1129","article-title":"Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci","author":"Van der Auwera","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0071","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijantimicag.2011.08.012","article-title":"Effect of telavancin on human intestinal microflora","author":"Rashid","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2019.10.008_bib0072","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/jac\/dkl281","article-title":"Effect of dalbavancin on the normal intestinal microflora","author":"Nord","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0073","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/19490976.2015.1062959","article-title":"Dynamic changes of the luminal and mucosa-associated gut microbiota during and after antibiotic therapy with paromomycin","author":"Heinsen","year":"2015","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jinf.2019.10.008_bib0074","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jac\/27.3.355","article-title":"Effect of oral spiramycin on the faecal and oral bacteria in human volunteers","author":"Andremont","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0075","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/46.5.741","article-title":"Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora","author":"Edlund","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0076","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/00365549109105189","article-title":"Comparative effects of clarithromycin and erythromycin on the normal intestinal microflora","author":"Brismar","year":"1991","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0077","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/inf.1982.14.issue-1.10","article-title":"Influence of erythromycin on the normal human flora and colonization of the oral cavity, throat and colon","author":"Heimdahl","year":"1982","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0078","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/AAC.35.3.548","article-title":"Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice","author":"Pecquet","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0079","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/BF01975827","article-title":"Impact of dirithromycin on the normal oral and intestinal microflora","author":"Eckernas","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0080","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1128\/AAC.00461-16","article-title":"Ecological Effect of Solithromycin on Normal Human Oropharyngeal and Intestinal Microbiota","author":"Rashid","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0081","first-page":"427","article-title":"Double-blind, placebo-controlled study comparing the effect of azithromycin with clarithromycin on oropharyngeal and bowel microflora in volunteers","author":"Matute","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0082","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.anaerobe.2014.10.004","article-title":"Development of antimicrobial resistance in the normal anaerobic microbiota during one year after administration of clindamycin or ciprofloxacin","author":"Rashid","year":"2015","journal-title":"Anaerobe"},{"key":"10.1016\/j.jinf.2019.10.008_bib0083","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/cid\/civ137","article-title":"Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods","author":"Rashid","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0084","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1128\/AAC.00068-15","article-title":"Impact of Ciprofloxacin and Clindamycin Administration on Gram-Negative Bacteria Isolated from Healthy Volunteers and Characterization of the Resistance Genes They Harbor","author":"Card","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0085","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ismej.2007.3","article-title":"Long-term ecological impacts of antibiotic administration on the human intestinal microbiota","author":"Jernberg","year":"2007","journal-title":"Isme j"},{"key":"10.1016\/j.jinf.2019.10.008_bib0086","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/jac\/dkl420","article-title":"Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes","author":"Lofmark","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0087","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/00365540802651897","article-title":"Prolonged impact of a one-week course of clindamycin on Enterococcus spp. in human normal microbiota","author":"Lindgren","year":"2009","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0088","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/00365540701199790","article-title":"Long-term antimicrobial resistance in Escherichia coli from human intestinal microbiota after administration of clindamycin","author":"Nyberg","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0089","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/AEM.71.1.501-506.2005","article-title":"Monitoring of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism","author":"Jernberg","year":"2005","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/08910609409141570","article-title":"Effect of Supplements with Bifidobacteriurn longum and Lactobacillus acidophilus on the Intestinal Microbiota during Administration of Clindamycin","author":"Orrhage","year":"1994","journal-title":"Microbial Ecology in Health and Disease"},{"key":"10.1016\/j.jinf.2019.10.008_bib0091","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijantimicag.2012.11.014","article-title":"Ecological impact of doxycycline at low dose on normal oropharyngeal and intestinal microflora","author":"Rashid","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2019.10.008_bib0092","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/inf.1983.15.issue-3.10","article-title":"Influence of doxycycline on the normal human flora and colonization of the oral cavity and colon","author":"Heimdahl","year":"1983","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0093","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jcph.236","article-title":"Tigecycline pharmacokinetics, tolerability, safety, and effect on intestinal microflora in healthy Japanese male subjects","author":"Yamashita","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0094","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/AAC.00373-06","article-title":"Effect of tigecycline on normal oropharyngeal and intestinal microflora","author":"Nord","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/49.1.135","article-title":"Impact of quinupristin\/dalfopristin (RP59500) on the faecal microflora in healthy volunteers","author":"Scanvic-Hameg","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0096","first-page":"67","article-title":"Quinolones and colonization resistance in human volunteers","author":"Van Saene","year":"1986","journal-title":"Pharm Weekbl Sci"},{"key":"10.1016\/j.jinf.2019.10.008_bib0097","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/00365548709032386","article-title":"Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics","author":"Edlund","year":"1987","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0098","first-page":"S41","article-title":"Influence of quinolones on throat- and faecal flora of healthy volunteers","author":"de Vries-Hospers","year":"1987","journal-title":"Pharm Weekbl Sci"},{"key":"10.1016\/j.jinf.2019.10.008_bib0099","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1128\/AAC.29.6.1047","article-title":"Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora","author":"Pecquet","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jac\/22.Supplement_C.115","article-title":"Pharmacokinetics of ofloxacin and the effect on the faecal flora of healthy volunteers","author":"Leigh","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0101","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01963066","article-title":"Effect of ofloxacin on oral and gastrointestinal microflora in patients undergoing gastric surgery","author":"Edlund","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0102","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1128\/AAC.31.1.124","article-title":"Effect of oral ofloxacin on fecal bacteria in human volunteers","author":"Pecquet","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0103","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF02017617","article-title":"Effect of enoxacin on colonic microflora of healthy volunteers","author":"Edlund","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0104","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jac\/22.Supplement_D.209","article-title":"Fleroxacin: safety, tolerance and effect on the faecal flora of healthy volunteers","author":"Shah","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01969531","article-title":"Effect of lomefloxacin on the normal oral and intestinal microflora","author":"Edlund","year":"1990","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0106","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jac\/27.5.655","article-title":"Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers","author":"Leigh","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0107","first-page":"e341","article-title":"Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota","volume":"344","author":"Stewardson","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2019.10.008_bib0108","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/jac\/dkx043","article-title":"Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers","author":"de Lastours","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0109","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1073\/pnas.1000087107","article-title":"Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation","author":"Dethlefsen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2019.10.008_bib0110","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1371\/journal.pbio.0060280","article-title":"The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing","author":"Dethlefsen","year":"2008","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0111","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1128\/AAC.41.8.1725","article-title":"Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate","author":"Krueger","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0112","first-page":"262","article-title":"Efficacy of oral ciprofloxacin as selective intestinal decontaminant in cirrhosis","author":"Borzio","year":"1997","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0113","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/00365549009037903","article-title":"Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption","author":"Ljungberg","year":"1990","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0114","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jac\/22.Supplement_C.127","article-title":"Gut decontamination by oral ofloxacin and ciprofloxacin in healthy volunteers","author":"van Saene","year":"1988","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0115","first-page":"641","article-title":"Intestinal microflora changes induced by ciprofloxacin and treatment of portal-systemic encephalopathy (PSE)","author":"Esposito","year":"1987","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.jinf.2019.10.008_bib0116","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF02013987","article-title":"Effect of oral ciprofloxacin on the faecal flora of healthy volunteers","author":"Holt","year":"1986","journal-title":"Eur J Clin Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0117","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/AAC.29.2.298","article-title":"Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora","author":"Bergan","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0118","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01645437","article-title":"Impact of oral ciprofloxacin on the faecal flora of healthy volunteers","author":"Enzensberger","year":"1985","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.10.008_bib0119","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/AAC.26.5.757","article-title":"Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers","author":"Brumfitt","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0120","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/00365549709011835","article-title":"Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora","author":"Edlund","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0121","first-page":"241","article-title":"The effect of levofloxacin, an optically-active isomer of ofloxacin, on fecal microflora in human volunteers","author":"Inagaki","year":"1992","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.jinf.2019.10.008_bib0122","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1128\/AAC.38.3.455","article-title":"Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora","author":"Ritz","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0123","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1179\/joc.1999.11.1.50","article-title":"Ecological effect of gatifloxacin on the normal human intestinal microflora","author":"Edlund","year":"1999","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0124","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1179\/joc.2001.13.1.47","article-title":"Impact of gemifloxacin on the normal human intestinal microflora","author":"Barker","year":"2001","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0125","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1128\/AAC.45.2.608-611.2001","article-title":"Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers","author":"Garcia-Calvo","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0126","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s150100070018","article-title":"Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone","author":"Oh","year":"2000","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.10.008_bib0127","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF02098093","article-title":"Influence of pefloxacin on microbial colonization resistance in healthy volunteers","author":"Vollaard","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0128","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jac\/35.6.895","article-title":"Comparison of rufloxacin and norfloxacin effects on faecal flora","author":"Marco","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1469-0691.2002.00414.x","article-title":"Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora","author":"Nord","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2019.10.008_bib0130","first-page":"368","article-title":"The effect of DU-6859a, a new potent fluoroquinolone, on fecal microflora in human volunteers","author":"Inagaki","year":"1995","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.jinf.2019.10.008_bib0131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0002-9610(98)00217-7","article-title":"A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers","author":"van Nispen","year":"1998","journal-title":"Am J Surg"},{"key":"10.1016\/j.jinf.2019.10.008_bib0132","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1128\/AAC.19.1.33","article-title":"Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone","author":"Guerrant","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0133","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/inf.1977.9.issue-3.11","article-title":"Sulphonamides in the treatment of acute Escherichia coli infection of the urinary tract in women. Clinical and ecological effects of sulphasomidine and sulphalene","author":"Lidin-Janson","year":"1977","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0134","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1017\/S0950268800067169","article-title":"Enterobacteriaceae suppression by three different oral doses of polymyxin E in human volunteers","author":"van Saene","year":"1988","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2019.10.008_bib0135","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/jac\/dkv062","article-title":"Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota","author":"Vervoort","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0136","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF01643751","article-title":"Influence of fosfomycin on the intestinal and pharyngeal flora of man","author":"Knothe","year":"1991","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.10.008_bib0137","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000222037","article-title":"Effect of fosfomycin on the fecal microflora of man","author":"Hendlin","year":"1977","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jinf.2019.10.008_bib0138","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.3748\/wjg.v23.i47.8355","article-title":"Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity","author":"Kaji","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0139","doi-asserted-by":"crossref","first-page":"e60042","DOI":"10.1371\/journal.pone.0060042","article-title":"Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy","author":"Bajaj","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2019.10.008_bib0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijantimicag.2014.03.016","article-title":"Ecological impact of MCB3837 on the normal human microbiota","author":"Rashid","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2019.10.008_bib0141","first-page":"e761","article-title":"Analysis of effects of MCB3681, the antibacterially active substance of prodrug MCB3837, on human resident microflora as proof of principle","volume":"767","author":"Dalhoff","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2019.10.008_bib0142","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1179\/joc.1997.9.3.203","article-title":"Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections","author":"Mavromanolakis","year":"1997","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0143","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jac\/44.5.629","article-title":"Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients","author":"Adamsson","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0144","doi-asserted-by":"crossref","first-page":"e9836","DOI":"10.1371\/journal.pone.0009836","article-title":"Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome","author":"Jakobsson","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2019.10.008_bib0145","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1046\/j.1365-2036.2001.01033.x","article-title":"Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora","author":"Buhling","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2019.10.008_bib0146","first-page":"81","article-title":"Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora","author":"Edlund","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0147","first-page":"899","article-title":"Ecological effects of linezolid versus amoxicillin\/clavulanic acid on the normal intestinal microflora","author":"Lode","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0148","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/00365549709019046","article-title":"Influence of low dose ciprofloxacin on microbial colonization of the digestive tract in healthy volunteers during normal and during impaired colonization resistance","author":"van de Leur","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0149","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jac\/34.1.127","article-title":"The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances","author":"Edlund","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0150","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1128\/AAC.48.10.3765-3772.2004","article-title":"Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers","author":"Pletz","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0151","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/jac\/38.5.839","article-title":"The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora","author":"D'Antonio","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2019.10.008_bib0152","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.01107-17","article-title":"Initial Gut Microbial Composition as a Key Factor Driving Host Response to Antibiotic Treatment, as Exemplified by the Presence or Absence of Commensal Escherichia coli","author":"Ju","year":"2017","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0153","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0022-3476(78)80523-X","article-title":"Bacterial colonization of neonates admitted to an intensive care environment","author":"Goldmann","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/j.jinf.2019.10.008_bib0154","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2019.10.008_bib0155","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/jgh.12073","article-title":"Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease","author":"Fujimoto","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0156","doi-asserted-by":"crossref","first-page":"e39743","DOI":"10.1371\/journal.pone.0039743","article-title":"Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2019.10.008_bib0157","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.gastro.2007.04.005","article-title":"The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects","author":"Kassinen","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jinf.2019.10.008_bib0158","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2217\/17460913.3.5.563","article-title":"Antibiotic-associated diarrhea: epidemiology, trends and treatment","author":"McFarland","year":"2008","journal-title":"Future Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0159","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jinf.2019.10.008_bib0160","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/514958","article-title":"Mechanisms and management of antibiotic-associated diarrhea","author":"Hogenauer","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0161","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3389\/fmicb.2018.01995","article-title":"Role of Short Chain Fatty Acids in Controlling Tregs and Immunopathology During Mucosal Infection","author":"Bhaskaran","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0162","doi-asserted-by":"crossref","first-page":"G1138","DOI":"10.1152\/ajpgi.00411.2015","article-title":"The SCFA butyrate stimulates the epithelial production of retinoic acid via inhibition of epithelial HDAC","author":"Schilderink","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0163","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1152\/physrev.2001.81.3.1031","article-title":"Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides","author":"Topping","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jinf.2019.10.008_bib0164","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2019.10.008_bib0165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","author":"Le Chatelier","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2019.10.008_bib0166","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ncomms2266","article-title":"Symptomatic atherosclerosis is associated with an altered gut metagenome","author":"Karlsson","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.jinf.2019.10.008_bib0167","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10408699891274200","article-title":"Butyric acid from the diet: actions at the level of gene expression","author":"Smith","year":"1998","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.jinf.2019.10.008_bib0168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2014.02.001","article-title":"Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38\/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat","author":"Khan","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jinf.2019.10.008_bib0169","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/db08-1637","article-title":"Butyrate improves insulin sensitivity and increases energy expenditure in mice","author":"Gao","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jinf.2019.10.008_bib0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1574-6968.2002.tb11467.x","article-title":"The microbiology of butyrate formation in the human colon","author":"Pryde","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.jinf.2019.10.008_bib0171","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/AEM.66.4.1654-1661.2000","article-title":"Phylogenetic relationships of butyrate-producing bacteria from the human gut","author":"Barcenilla","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0172","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1099\/00207713-51-1-39","article-title":"Clostridium hiranonis sp. nov., a human intestinal bacterium with bile acid 7alpha-dehydroxylating activity","author":"Kitahara","year":"2001","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.jinf.2019.10.008_bib0173","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/00365540701299608","article-title":"Macrolide resistance in the normal microbiota after Helicobacter pylori treatment","author":"Jakobsson","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2019.10.008_bib0174","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-139-6-200309160-00011","article-title":"Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori","author":"Sjolund","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2019.10.008_bib0175","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJM197704072961403","article-title":"Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora","author":"Stamey","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2019.10.008_bib0176","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000221918","article-title":"Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora","author":"Toivanen","year":"1976","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jinf.2019.10.008_bib0177","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134941","article-title":"Effects of Long Term Antibiotic Therapy on Human Oral and Fecal Viromes","author":"Abeles","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319303184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319303184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:28:52Z","timestamp":1759008532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445319303184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":177,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0163445319303184"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2019.10.008","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of antibiotics on the composition of the intestinal microbiota - a systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2019.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}